Search Results

You are looking at 1 - 1 of 1 items for :

  • glucagon-like peptide-1 x
  • Refine by access: All content x
Clear All
Jonathan D Douros Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana, USA

Search for other papers by Jonathan D Douros in
Google Scholar
PubMed
Close
,
Jacek Mokrosinski Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana, USA

Search for other papers by Jacek Mokrosinski in
Google Scholar
PubMed
Close
, and
Brian Finan Novo Nordisk Research Center Indianapolis, Indianapolis, Indiana, USA

Search for other papers by Brian Finan in
Google Scholar
PubMed
Close

disadvantageous regulatory mechanisms in a cell-targeted, pathophysiology-specific manner. This review aims to outline the current understanding of signaling bias at the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) in three broad categories: (i) ligand

Restricted access